Top 20 of Hypercholesterolemia

Article title # Publications/# Citations

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

2001: Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults;

2385

Atherosclerosis--an inflammatory disease.

1999: RRoss;

1740

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

2002: National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);

1513

Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

2010: American Heart Association Statistics Committee and Stroke Statistics Subcommittee; RJAdams; JDBerry; TMBrown; MRCarnethon; SDai; Gde Simone; ESFord; ... CSFox; HJFullerton; CGillespie; ASGo; KJGreenlund; SMHailpern; JAHeit; PMHo; VJHoward; BMKissela; SJKittner; DTLackland; JHLichtman; LDLisabeth; DMLloyd-Jones; DMMakuc; GMMarcus; AMarelli; DBMatchar; MMMcDermott; JBMeigs; CSMoy; DMozaffarian; MEMussolino; GNichol; NPPaynter; VLRoger; WDRosamond; PDSorlie; RSStafford; TNTuran; MBTurner; NDWong; JWylie-Rosett;

807

Inflammation, atherosclerosis, and coronary artery disease.

2005: GKHansson;

723

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994:

593

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

2005: Cholesterol Treatment Trialists' (CTT) Collaborators; CBaigent; LBlackwell; GBuck; RCollins; PMKearney; AKeech; AKirby; ... RPeto; CPollicino; RSimes; TSourjina;

531

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.

2004: American College of Cardiology Foundation; American Heart Association; National Heart, Lung, and Blood Institute; HBBrewer; LTClark; JICleeman; SMGrundy; DBHunninghake; ... CNMerz; RCPasternak; SCSmith; NJStone;

516

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

1995: SMCobbe; IFord; CGIsles; ARLorimer; PWMacfarlane; JHMcKillop; CJPackard; JShepherd;

483

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

1992: NMaeda; JAPiedrahita; RLReddick; SHZhang;

335

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

1992: KAalto-Setälä; JLBreslow; THayek; ASPlump; EMRubin; JDSmith; JGVerstuyft; AWalsh;

332

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

2007: LACupples; RBD'Agostino; CSFox; UHoffmann; CYLiu; JMMassaro; PMaurovich-Horvat; JBMeigs; ... JMMurabito; CJO'Donnell; KMPou; RSVasan;

263

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.

1994: JLBreslow; YNakashima; ASPlump; EWRaines; RRoss;

254

Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.

1993: MSBrown; RDGerard; JLGoldstein; REHammer; JHerz; SIshibashi;

247

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata.

2007: EAikawa; PAlcaide; PLibby; FWLuscinskas; MJPittet; FKSwirski; RWeissleder;

232

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

1987: OElo; MHFrick; KHaapa; OPHeinonen; PHeinsalmi; PHelo; JKHuttunen; PKaitaniemi; PKoskinen; VManninen;

226

State of disparities in cardiovascular health in the United States.

2005: JBCroft; ESFord; KJGreenlund; GAMensah; AHMokdad;

215

Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

1974: MSBrown; JLGoldstein;

184

MiR-33 contributes to the regulation of cholesterol homeostasis.

2010: ADávalos; CFernández-Hernando; EAFisher; MLFitzgerald; KJMoore; SParathath; KJRayner; YSuárez; NTamehiro;

178

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

2007: Japan EPA lipid intervention study (JELIS) Investigators; HHishida; YIshikawa; HItakura; TKita; AKitabatake; MMatsuzaki; YMatsuzawa; ... NNakaya; SOikawa; HOrigasa; YSaito; TSakata; JSasaki; KShimada; KShirato; MYokoyama;

174